Allworth Financial’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1K Sell
321
-1
-0.3% -$42 ﹤0.01% 3709
2026
Q1
$17.8K Buy
322
+24
+8% +$1.14K ﹤0.01% 3078
2025
Q4
$11.2K Buy
298
+221
+287% +$8.98K ﹤0.01% 3197
2025
Q3
$3.12K Hold
77
﹤0.01% 3801
2025
Q2
$1.97K Buy
77
+50
+185% +$1.09K ﹤0.01% 3710
2025
Q1
$487 Hold
27
﹤0.01% 3681
2024
Q4
$588 Buy
+27
New +$625 ﹤0.01% 3556
2023
Q2
Sell
-68
Closed -$1.04K 3343
2023
Q1
$1.04K Buy
+68
New +$1.04K ﹤0.01% 2656
2021
Q2
Sell
-100
Closed -$2K 1641
2021
Q1
$2K Hold
100
﹤0.01% 1321
2020
Q4
$2K Hold
100
﹤0.01% 1185
2020
Q3
$2K Hold
100
﹤0.01% 1011
2020
Q2
$3K Hold
100
﹤0.01% 958
2020
Q1
$2K Hold
100
﹤0.01% 1073
2019
Q4
$2K Hold
100
﹤0.01% 927
2019
Q3
$2K Hold
100
﹤0.01% 840
2019
Q2
$3K Hold
100
﹤0.01% 769
2019
Q1
$3K Hold
100
﹤0.01% 779
2018
Q4
$3K Buy
+100
New +$3.77K ﹤0.01% 692

Other funds holding PAHC

Allworth Financial's PAHC Position: Q2 2026 in Review

Allworth Financial reduced its Phibro Animal Health (PAHC) stake by 0.31% in Q2 2026, selling an estimated $42 and leaving 321 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3709.

Allworth Financial first reported a position in PAHC in Q4 2018 and has held it in 18 quarters since. The position peaked at $17.8K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Allworth Financial held 321 shares of Phibro Animal Health worth $10.1K as of Q2 2026.
  • Allworth Financial sold 1 Phibro Animal Health share in Q2 2026, an estimated $42.
  • Phibro Animal Health made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3709 holding.
  • Allworth Financial first reported a position in Phibro Animal Health in Q4 2018 and has held it in 18 quarters since.
  • Allworth Financial's Phibro Animal Health position peaked at $17.8K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.